Female athletes’ decisions to use hormonal contraceptives: a scoping review protocol.
| dc.contributor.author | Suarez Moreno, Paula | |
| dc.contributor.author | Van Den Berg, Carla | |
| dc.contributor.author | Hayden, K. Alix | |
| dc.contributor.author | Doyle-Baker, Patricia K. | |
| dc.date.accessioned | 2024-03-21T19:54:41Z | |
| dc.date.available | 2024-03-21T19:54:41Z | |
| dc.date.issued | 2024 | |
| dc.description | Scoping review protocol for scoping review investigating female athletes' decisions to use hormonal contraceptives | |
| dc.description.abstract | Female athletes from a variety of sports indicate a perceived impact of the menstrual cycle (MC) on their performance (Brown et al., 2021; Ekenros et al., 2022; Findlay et al., 2020). Female athletes often choose to use hormonal contraceptives (HC’s) and although their reasons vary, the most consistent one is related to the impact of the MC on performance and training. For example, in a study by Martin et al., (2018) a third of 145 combined oral contraceptive athlete users perceived that cycle manipulation to avoid menstruation can be considered a positive outcome of oral contraceptive use. Therefore, the objective of this scoping review is to investigate the extent of evidence associated with the reasons behind female athletes’ decision to use or discontinue use of hormonal contraceptives. The inclusion criteria included a) female (sex assigned at birth), b) athletes actively participating in competition, of which the majority are competing at least a regional level (Swann et al., 2015), c) sample is mostly age 18 years or older, d) discusses knowledge, reasons, perceptions, attitudes, beliefs of the athletes as related to their decisions regarding HC use and e) discusses history of hormonal contraceptive use either current or previous as an athlete. The JBI guidelines for scoping reviews found in the JBI Manual for Evidence Synthesis (2020) will be followed and this review will be reported in accordance with the PRISMA –SCr extension (Peters et al., 2020; Tricco et al., 2018). | |
| dc.identifier.uri | https://hdl.handle.net/1880/118289 | |
| dc.identifier.uri | https://doi.org/10.11575/PRISM/43132 | |
| dc.language.iso | en | en |
| dc.publisher.institution | University of Calgary | en |
| dc.rights | Unless otherwise indicated, this material is protected by copyright and has been made available with authorization from the copyright owner. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. | en |
| dc.subject | Hormonal contraceptives | |
| dc.subject | athletes | |
| dc.subject | prevalence | |
| dc.subject | menstrual cycle | |
| dc.title | Female athletes’ decisions to use hormonal contraceptives: a scoping review protocol. | |
| dc.type | Other | |
| ucalgary.scholar.level | Graduate, Faculty |